Yang Xie
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 10
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 4
- Hematology top 10%
-
- Cancer, Hypoxia, and Metabolism 3
-
- Peroxisome Proliferator-Activated Receptors 3
- Epigenetics and DNA Methylation 3
-
- Liver Disease Diagnosis and Treatment 4
-
- Childhood Cancer Survivors' Quality of Life 3
- Co-authors
- Julie A. RossLeslie L. RobisonStella M. DaviesYing XiangWen XieHaiping HaoXuefang ChengGuangji Wang
- Cited by
- OncologyPharmacologyHematology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yang Xie
42 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Oncology 410
- Pharmacology 122
- Hematology 132
- Cancer Research 130
- Molecular Biology 592
Countries citing papers authored by Yang Xie
This map shows the geographic impact of Yang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Xie more than expected).
Fields of papers citing papers by Yang Xie
This network shows the impact of papers produced by Yang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Xie. The network helps show where Yang Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 17 | |
| 6 | 2023 | 8 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 16 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 8 | |
| 12 | 2017 | 17 | |
| 13 | 2016 | 29 | |
| 14 | 2015 | 20 | |
| 15 | [Progress in the role of farnesoid X receptor in metabolic regulation and tumor cell proliferation]. | 2014 | 1 |
| 16 | 2012 | 19 | |
| 17 | 2012 | 19 | |
| 18 | 2008 | 9 | |
| 19 | 2003 | 180 | |
| 20 | 2003 | 8 |
About Yang Xie
Yang Xie is a scholar working on Pharmacology, Oncology and Hepatology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (8 papers), Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (410 citations), Pharmacology (122 citations) and Hematology (132 citations). Yang Xie has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Julie A. Ross, Leslie L. Robison, Stella M. Davies, Ying Xiang, Wen Xie, Haiping Hao, Xuefang Cheng, Guangji Wang, Lijuan Cao and Joseph D. Growney. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.